Attovia Therapeutics, Inc. (ATTO)
22.93
-0.73
(-3.09%)
USD |
NASDAQ |
Sep 09, 16:00
22.93
0.00 (0.00%)
After-Hours: 16:18
Attovia Therapeutics Total Assets (Quarterly) : 128.35M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 128.35M |
| Date | Value |
|---|---|
| March 31, 2026 | 146.09M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.58M |
| Shareholders Equity (Quarterly) | 112.77M |
| Debt to Equity Ratio | 0.0384 |
| Current Ratio | 9.386 |